Sixteen female cross-bred (Large White £ Landrace) pigs (initial weight 65 kg) with venous catheters were randomly allocated to four treatment groups in a 2 £ 2 factorial design. The respective factors were dietary fat (25 or 100 g/kg) and dietary conjugated linoleic acid (CLA; 0 or 10 g CLA-55/kg). Pigs were fed every 3 h (close to ad libitum digestible energy intake) for 8 d and were bled frequently. Plasma glucose and non-esterified fatty acid (NEFA) responses to insulin and adrenaline challenges were determined on day 8. Plasma concentrations of NEFA were significantly increased (10·5 and 5·4 % for low-and high-fat diets respectively, P¼0·015) throughout the experiment, suggesting that there was a possible increase in fat mobilisation. The increase in lipolysis, an indicator of ß-adrenergic stimulated lipolysis, was also evident in the NEFA response to adrenaline. However, the increase in plasma triacylglycerol (11·0 and 7·1 % for low-and high-fat diets respectively, P¼0·008) indicated that CLA could have reduced fat accretion via decreased adipose tissue triacylglycerol synthesis from preformed fatty acids, possibly through reduced lipoprotein lipase activity. Plasma glucose, the primary substrate for de novo lipid synthesis, and plasma insulin levels were unaffected by dietary CLA suggesting that de novo lipid synthesis was largely unaffected (P¼0·24 and P¼ 0·30 respectively). In addition, the dietary CLA had no effect upon the ability of insulin to stimulate glucose removal.
The potential of conjugated linoleic acids (CLA) to reduce body fat deposition has been well documented (Albright et al. 1996; Park et al. 1997; West et al. 1998; DeLany et al. 1999; Ostrowska et al. 1999; Park et al. 1999a,b; Satory & Smith, 1999) , but whether the reduction in fat deposition is due to increased lipolysis (fat breakdown) or decreased lipogenesis (fat synthesis) is unclear. One way to understand the in vivo metabolic responses to CLA better is by studying the temporal pattern of intermediate metabolite and hormone concentrations. The effect of CLA treatment on lipolysis can be further investigated by determining the metabolic responses to homeostatic signals, such as adrenaline or insulin. Adrenaline stimulates ß-adrenergic lipolysis (Sechen et al. 1990; Dunshea & King, 1995) , whereas insulin enhances storage of fat while inhibiting the mobilisation and oxidation of fatty acids in vivo Dunshea & King, 1995) . Quantifying the plasma glucose response to insulin may also help to establish whether CLA induces insulin resistance, as this is characterised by high levels of plasma glucose and insulin (Dunshea & King, 1994) . These techniques have previously been used to determine the mode of action of metabolic modifiers such as somatotropin (Sechen et al. 1990; Boisclair et al. 1994) and ractopamine Dunshea & King, 1995) .
The first objective of the present study was to determine the effect of the CLA treatment on plasma variables related to lipolysis and lipogenesis in growing pigs. The second objective was to measure the metabolic responses to the homeostatic signals, adrenaline and insulin.
Experimental methods

Animals and treatments
All procedures involving animals were approved by the Victorian Institute of Animal Science Animal Ethics Committee. Twenty female cross-bred (Large White £ Landrace) gilts (initial weight 65 kg) were catheterised 7 d before commencement of the study. Muscle relaxation was induced with an intramuscular injection of xylazine (20 mg xylazine.HCl/ml; Troy Labs Pty. Ltd, Smithfield, New South Wales, Australia) and ketamine (100 mg ketamine.HCl/ml; Troy Labs Pty. Ltd) at 0·05 ml and 0·1 ml/ kg body weight respectively. The anaesthesia was maintained with halothane (Rhone Merieux, Footscray West, Victoria, Australia) inhalation. A silastic catheter was inserted 0·15 m into the anterior vena cava via the cephalic vein. The catheter was exteriorised in the region of interscapular space on the back of each animal and stored in a cloth pocket glued to the back. After catheterisation, pigs were given 10 mg broad-spectrum antibiotic Engemycin 100 (100 mg oxytetracycline hydrochloride/ml; Intervet (Australia) Pty. Ltd, Castle Hill, New South Wales, Australia)/kg body weight. The twenty surgically prepared gilts were monitored for feeding behaviour, rectal temperature, general disposition and defecation frequency. Any pigs with elevated temperatures (. 398C) were given 5 mg Penbritin (ampicilin sodium; Beecham Veterinary Products, Dandenong, Victoria, Australia)/kg body weight. Catheters were flushed daily with physiological saline containing K 2 EDTA (12·5 g/l). The sixteen gilts with the best functional catheters were blocked on live weight and within blocks randomly allocated to four treatment groups in a 2 £ 2 factorial design. The respective factors were level of dietary CLA (0 and 10 g/kg) and total dietary fat (25 and 100 g/kg).
Four days before the initiation of the dietary treatments, all pigs were fed a diet containing no CLA and an intermediate fat level (about 60 g/kg) (75 kJ digestible energy/ kg live weight) every 3 h (about 2·5 kg feed/d for a 60 kg pig or approximately 90 % ad libitum digestible energy) to ensure a relatively steady state for measuring plasma metabolites. On day 1, pigs were offered their respective experimental diets at the same rate and frequency for 8 d. Pigs were fed either a low-fat diet (total fat 25 g/kg; Table 1 ) or a high-fat diet (total fat 100 g/kg; Table 1 ) with either 0 or 10 g CLA-55 (CLA containing 55 g fatty acids as CLA isomers/100 g total fatty acids; Natural Lipids Ltd, Hovdebygda, Norway)/kg. Pigs were fed for 8 d, during which time they were bled frequently (see later). The added fat in the high-fat diet was provided as palm oil, thereby ensuring that saturated fatty acids were the predominant preformed fatty acids. The wheat-based diets were formulated to contain 14 and 15 MJ digestible energy/kg low-and high-fat diet respectively.
After commencing the dietary treatments, all pigs were bled (8 ml blood) at intervals of 3 h (immediately before each feeding) for 48 h. From day 3 until day 7 pigs were bled twice per d immediately prior to feeding at 09.00 and 18.00 hours. Previous studies have demonstrated that plasma metabolites are in a steady state in pigs fed at intervals of 2 to 4 h (Dunshea et al. 1992a; Dunshea & King, 1994) and it was felt that two samples taken 9 h apart would be representative of plasma metabolite concentrations in these pigs. A subsequent 24 h bleed took place on day 7 (at intervals of 3 h for 24 h). Blood was collected by first removing the contents of the cannula with a syringe and discarding it. The syringe was then attached to the cannula and blood was withdrawn to ensure unrestricted blood flow. The cannulas were flushed and re-filled after blood collections with anticoagulant (12·5 g K 2 EDTA/l saline (0·15 M-NaCl)) and were secured in the pouch.
Challenges
On the morning of day 8, half the animals from each dietary treatment were challenged with a dose (3 mg/kg body weight) of insulin (Astra Pharmaceuticals Pty. Ltd, North Ryde, New South Wales, Australia) diluted in sterile saline (0·15 M-NaCl). Adrenaline (1·82 mg adrenaline acid tartrate/ml; Astra Pharmaceuticals Pty. Ltd) diluted in sterile saline (0·15 M-HCl) was administered to the remaining pigs via the catheter (3 mg/kg body weight). The injections were reversed in the afternoon. Both the adrenaline and insulin were injected via the catheter, immediately followed by 5 ml sterile saline. Blood (5 ml) was collected frequently for 1 h before and 2 h after each injection. The bleeding for each challenge took place at 2 60, 2 30, 2 15, 2 1, 3, 6, 10, 15, 20, 30, 45, 60, 90 , 120 min relative to the injections. Pre-bleeding for basal samples commenced 30 min before feed was dispensed for the feeds at 09.00 and 15.00 hours. Plasma glucose and non-esterified fatty acid (NEFA) responses to insulin and adrenaline were determined on day 8. The following day, the catheters were removed. Whole blood was stored on ice immediately after the bleeding and centrifuged at 2000 g to separate the plasma. Plasma was portioned into three separate vials and stored at 2 208C until analysed for metabolite concentrations.
Chemical analysis
Plasma triacylglycerol concentrations were analysed using an Infinitye Triacylglycerol Reagent kit (procedure no. 343; Sigma-Aldrich Pty. Ltd, Castle Hill, New South Wales, Australia). Plasma glucose and urea N concentrations were analysed using a Sigma kit (procedure no. 510 and no. 640 respectively; Sigma-Aldrich Pty. Ltd). Both assays were modified to accommodate the range of concentrations of plasma glucose and plasma urea encountered in the pig. Plasma insulin was measured using a porcine insulin radioimmunoassay kit (catalogue no. PI-12 K; Linco Research, Inc., St Charles, MO, USA). Plasma NEFA levels were assayed using NEFA C ACS-ACOD method (Wako Pure Chemicals Industries Ltd, Doshomachi 3-Chome, Chuo-Ku, Osaka 541, Japan) modified for microtitre plates (Johnson & Peters, 1993) .
Statistical analysis
The experimental design included four treatment groups in a 2 £ 2 factorial design. Average daily concentrations of key metabolites and hormones in plasma during the treatment period were compared using a repeated-measures mixed model analysis (Genstat for Windows, version 4.1; Payne et al. 1993 ). The respective factors were level of dietary CLA (0 and 10 g/kg) and total fat in the diet (25 and 100 g/kg) and day. Responses to insulin and adrenaline challenges on day 8 were assessed by comparing the area under the metabolite concentration v. time curve. Data were analysed by ANOVA.
Results
Growth
There were no significant effects of CLA on average daily gain (P¼ 0·77) or feed conversion ratio (P¼ 0·87) ( Table 2) . By design, the group of pigs fed the high-fat diet consumed significantly less feed per d than the group of pigs fed a low-fat diet (P¼ 0·006), ensuring a similar overall energy intake for the two groups. Feed intake was not significantly reduced by dietary CLA (P¼ 0·11).
Effects of dietary fat and conjugated linoleic acid on plasma metabolite levels Table 3 shows the average plasma metabolite levels over the first 7 d of feeding. Plasma NEFA levels in pigs fed the high-fat diet (Table 3) were significantly higher than in pigs fed diets lower in fat (P, 0·001). Dietary CLA also increased plasma NEFA such that pigs fed CLAsupplemented diets had 10·5 and 5·4 % (for low-and high-fat diets respectively) higher average plasma NEFA levels than pigs fed with basal diets (P¼ 0·015) ( Table  3 ). For pigs fed the high-fat diet, the increase in baseline concentrations of NEFA appeared to be most pronounced during the first 2 d after the commencement of the present study, although this was not indicated by any interaction between dietary CLA and time. The baseline concentration of plasma triacylglycerol was 9 % higher (P¼ 0·008) when CLA supplement was added to the diet and 13 % greater (P¼ 0·001) for high-v. low-fat diets (Table 3 ). The increase in plasma triacylglycerol due to CLA supplementation was 11 and 7 % for low-and high-fat diets respectively. There was a linear interaction (P, 0·001) between time and dietary fat content such that the plasma triacylglycerol concentrations increased with time in pigs fed the high-fat diet and remained relatively constant in pigs fed the low-fat diet (Table 3) . Plasma glucose concentrations were not affected by dietary CLA treatment (P¼ 0·24) or dietary fat (P¼ 0·39) treatment (Table 3) . Similarly, the average plasma insulin levels were unaffected by dietary CLA (P¼ 0·30), but were significantly higher (P¼ 0·04) in pigs fed the lowfat diet compared with pigs fed the high-fat diet (Table  3) . Plasma urea concentrations were significantly lower (P¼ 0·001) in pigs fed the low-fat diets compared with pigs fed the high-fat diets. The plasma urea concentrations were not significantly reduced (P¼ 0·13) in pigs fed dietary CLA (Table 3) .
Adrenaline and insulin challenges
The plasma NEFA and glucose responses to intravenous Statistical significance of effect: P CLA-55 (g/kg) †. . .
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adrenaline or insulin injection are shown in Figs. 1 -4 . The metabolic responses to both of these homeostatic signals were evident within minutes, before quickly returning to the levels recorded prior to the challenge. The calculated areas under the metabolite time curves are presented in Table 4 . The intravenous injection of adrenaline stimulated lipolysis, as shown by an acute increase in plasma NEFA levels in all pigs. The lipolytic response, as indicated by area under the curve corrected for baseline, was significantly higher (P¼ 0·018) in pigs fed dietary CLA than in pigs fed the basal diets (Table 4 , Fig. 1(a) ). Prior to the injection of adrenaline, the basal plasma NEFA concentrations were significantly (P, 0·02) higher in pigs fed the high-fat diet. After the adrenaline challenge, the increase in NEFA area under the curve was similar (P¼ 0·78) to that of pigs fed the low-fat diet ( Fig. 1(b) ). The intravenous injection of adrenaline caused mild hyperglycaemia as shown by an increase in plasma glucose area under the curve in all dietary treatments (Fig. 2) . Plasma glucose area under the curve after adrenaline injection was significantly reduced (34 -41 %, P¼ 0·007) in pigs fed the high-fat diet, but not significantly reduced (17 -26 %, P¼ 0·12) by dietary CLA (Table 4) .
The anti-lipolytic effects of insulin were relatively modest (Fig. 3) . Although there was a significantly greater (P¼ 0·036) plasma NEFA area under the curve in response to insulin over the first 6 min of the challenge in pigs fed CLA, the area under the curve was not significantly different over the interval between 0 and 20 min after the challenge ( Fig. 3(a) , Table 4 ). There was no significant difference in plasma NEFA response (P¼ 0·98) between pigs fed different levels of dietary fat (Table 4) . On the other hand, there was a marked hypoglycaemia in response to insulin injection (Fig. 4) although there was no effect of either dietary CLA (P¼ 0·86) or fat (P¼ 0·84) on the magnitude of this response (Fig. 4, Table 4 ).
Discussion
The present study was designed to investigate the interactions between dietary energy source and CLA using catheterised pigs. While growth performance data are notoriously unreliable over short periods, it is worth reporting that there were no significant effects of CLA on average daily gain or feed conversion ratio over the 8 d of the study. In addition, no significant interactions were observed between CLA and the fat content in the diet for daily gain, energy intake or feed intake. However, feed intake tended to be reduced (2 5 %) by dietary CLA, although this was not significant (P¼ 0·11). Other studies have reported a reduction in feed intake associated with CLA feeding in mice, in particular in the early stages (the first 3 weeks) of feeding relatively high levels of CLA (. 10 g/kg) (West et al. 1998) . However, the small suppression in energy intake associated with CLA treatment could not be entirely responsible for the large loss of body fat content in mice reported by West et al. (1998) as well as the reduction in fat accretion in pigs (Ostrowska et al. 1999) . Other possible mechanisms involved include the inhibition of fat deposition from both preformed fatty acids (lipogenesis) or glucose (de novo lipogenesis) and/or an increase in fat mobilisation (lipolysis) in pigs fed dietary CLA. Plasma metabolites and hormones as well as acute responses to homeostatic hormones that may indicate changes in these three possible mechanisms for reduced fat accretion in pigs fed CLA were therefore investigated in the present study.
Evidence of reduced rate of lipogenesis
Given that pigs are generally fed a high-carbohydrate diet (Dunshea et al. 1992a) , de novo lipogenesis, a process whereby carbohydrates are converted to triacylglycerol and stored in the adipose tissue, would represent the major mechanism for lipid synthesis (Dunshea et al. 1992a) . Thus, intuitively, it would be likely that CLA acts to reduce the rate of de novo lipogenesis. However, West et al. (1998) reported that the carcass fat content was decreased in CLA-treated mice regardless of whether they were fed either a high-carbohydrate or a high-fat diet. The metabolic results from the present study also showed no significant interactions between the dietary CLA and the total fat contents, suggesting that CLA exerts similar effects in pigs fed either a high-carbohydrate or a high-fat diet. Hence, in both studies the rates of de novo synthesis as well as the use of preformed fatty acids might be reduced by dietary CLA. In order to study fat transport and metabolism, the key metabolites and hormones (including triacylglycerol, NEFA, glucose and insulin) involved in the process of lipid synthesis were monitored during CLA supplementation. Fatty acids for lipogenesis can be produced de novo, principally from glucose in adipose tissue, and the uptake of glucose into skeletal muscle and adipose tissue is regulated by insulin (Dunshea et al. 1992b) . Therefore, changes in the rate of lipid deposition may be reflected in the levels of these plasma metabolites. For example, pigs fed the high-fat diet had higher plasma triaclyglycerol concentrations than pigs fed the low-fat diet (Table 3) . In turn, this may have resulted in the higher rate of hydrolysis of circulating triacylglycerol originating from the high-fat diet, hence the higher circulating plasma NEFA levels (Table 3) .
Pigs fed the CLA-containing diets had higher plasma NEFA concentrations than the pigs fed diets without CLA, regardless of dietary fat content, and this response appeared to be most pronounced over the first 2 d of CLA feeding. One of the contributing factors could be a reduced uptake of the NEFA resulting from hydrolysis of circulating triacylglycerol catalysed by lipoprotein lipase at the epithelial cell surface. A reduced uptake of preformed fatty acids is clearly indicated by the higher levels of circulating triacylglycerol in pigs fed diets containing CLA, despite the tendency towards a reduced feed intake, and thus dietary fat intake, in these pigs. Likewise, others have also found a substantial, although C, effect of dietary CLA; F, effect of dietary fat; NEFA, non-esterified fatty acid. * For details of diets and procedures, see Table 1 and p. 626. † CLA nominally contained 55 g fatty acids as CLA isomers/100 g total fatty acids. ‡ Standard error of the difference for C £ F. § Sum of response over first 6 min. k Sum of response over first 30 min.
non-significant increase (24 %) in serum triacylglycerol in pigs fed CLA (O'Quinn et al. 1998; Stangl et al. 1999 ). An increase in plasma triacylglycerol levels in pigs fed supplemental CLA could be an indication of reduced activity of lipoprotein lipase. In this context, Park et al. (1997) found that CLA decreased the heparin-releasable lipoprotein lipase activity in 3T3-L1 cultured murine adipocytes. Therefore, it is reasonable to hypothesise that a major effect of CLA on fat accretion is via decreased lipid synthesis from preformed fatty acids possibly through reduced lipoprotein lipase activity. Investigations with lactating cows indicate that the major effect of CLA on milk fat synthesis is due to a reduced rate of de novo synthesis (Chouinard et al. 1999; Baumgard et al. 2001b) . CLA was also shown to reduce the mRNA abundance of lipogenic enzymes including acetyl-CoA carboxylase and fatty acid synthetase, two key enzymes in de novo fatty acid synthesis, in adipose tissue of growing mice (Tsuboyama-Kasaoka et al. 2000) and in lactating cows (Baumgard et al. 2001a) . However, there was no change in enzyme activity in weaned pigs fed CLA (Bee, 2000) . To investigate this further, the level of plasma glucose, which is the primary substrate for de novo lipid synthesis, was monitored in the present study. The uptake of glucose is dependent upon insulin, hence the level of this hormone was also examined. In the present study, dietary CLA had little effect upon plasma insulin concentrations. Furthermore, no hyperglycaemic responses were evident throughout the study indicating that glucose production and utilisation were not markedly influenced by dietary CLA. However, the insulin:glucose ratio, which is used as a measure of insulin sensitivity in rodents and human subjects (Legro et al. 1998; Harder et al. 1999) tended to increase (P¼ 0·13) with dietary CLA, particularly in pigs fed the low-fat diet. While this may be indicative of slight insulin resistance, it was definitely not comparable with that observed in rodents (DeLany & West, 2000; Tsuboyama-Kasaoka et al. 2000) .
The rates of glucose clearance, and by inference a component of lipogenesis, were further studied by intravenous infusion of insulin. Insulin, a hormone secreted by the ß cells of the pancreas, plays a predominant role in the lipogenic process. When challenged with insulin, pigs fed the CLA-supplemented diets appeared to be relatively resistant to the anti-lipolytic effects of insulin, as indicated by little change in plasma NEFA concentrations over the first 6 min after insulin injection. On the other hand, plasma NEFA concentrations did decrease, albeit only slightly, in response to insulin injection in the pigs fed diets containing no CLA. The marginal NEFA responses to insulin are consistent with very low rates of basal lipolysis in the growing pig (Dunshea et al. 1992c ) and under these conditions, it is very difficult to demonstrate an anti-lipolytic effect of insulin (Dunshea et al. 1992c; Dunshea & King, 1995) . Given the significant, but moderate, difference in NEFA response between pigs fed different CLA levels, it is perhaps judicious not to place too much emphasis on effects of CLA on insulin responses, particularly given the failure to observe any difference in glucose metabolism after insulin injection.
Plasma glucose clearance after insulin challenge was not altered by CLA treatment indicating no change in wholebody response in glucose uptake. Studies in pre-diabetic Zucker fatty rats have shown that only at higher concentrations of supplemental CLA isomer mix (15 g/kg) is there any improvement in glucose tolerance and insulin sensitivity, due to increased uptake of glucose and insulin levels in skeletal muscle (Houseknecht et al. 1998) . Houseknecht et al. (1998) proposed that CLA induced the peroxisome proliferator-activated receptor expression, most probably proliferator-activated receptor-g, a key regulator of insulin sensitivity. The same group of researchers (Ryder et al. 2001) later attributed these responses to the trans-10,cis-12-CLA isomer. It should also be noted that effects of CLA on insulin sensitivity are more likely to be observed in animals with metabolic disorders, such as in the Zucker rat, rather than in normal animals as used in the present study. In this context, recent studies in lactating cows showed that abomasal infusion of trans-10,cis-12-CLA isomer had no effect on the plasma glucose response to an insulin challenge (Baumgard et al. 2002) .
Evidence of increased rate of lipolysis
It is also possible that CLA could exert its effect on lipolysis. The triacylglycerol within the adipocyte can be hydrolysed by hormone sensitive lipase into NEFA and glycerol (Pethick & Dunshea, 1993) . The rate of fat mobilisation may be sufficiently increased to result in the net reduction in lipid accretion observed in pigs fed dietary CLA. Therefore, the small, but significant (P¼ 0·015) increase in plasma NEFA in the CLA-fed pigs could be due to increased fat breakdown and enhanced rate of movement of fatty acids into b-oxidation for ATP production. In vitro work with 3T3-L1 adipose cells supported the evidence that CLA potentially enhanced lipolysis and it was attributed to an increase of the carnitine palmitoyl transferase activity, both in the adipose tissue of the fed animals and in the skeletal muscle of fasted mice (Park et al. 1997) . If increased fat mobilisation was the source of increased plasma NEFA in CLA-fed pigs, it would only be a very small component (about 6 g/d) (Dunshea et al. 1992a,b) of the reduction (86 g/d) in fat accretion in pigs fed this level of CLA (Ostrowska et al. 1999 ) based on the relationship between plasma NEFA concentrations and NEFA turnover rate (Dunshea et al. 1992c) . Hence, it is unlikely that the major component of the reduced fat deposition due to CLA supplementation is a result of increased lipolysis. In this context, there was no change in plasma NEFA in lactating cows infused with the trans-10,cis-12-CLA isomer (Baumgard et al. 2002 ).
An additional indication of an increase in adipose tissue fat mobilisation during CLA feeding was provided by the greater increase (+126 %) in plasma NEFA after an intravenous adrenaline injection on day 8 of the study (Fig. 3) . Since the plasma NEFA response to adrenaline is an indicator of ß-adrenergic stimulated lipolysis (Sechen et al. 1990; Dunshea & King, 1995) , these results suggest that this response was heightened during CLA feeding. In dairy cows, infusion of trans-10,cis-12-CLA, the biologically active isomer that causes a marked reduction in milk fat synthesis, had little effect on NEFA concentrations (basal lipolysis) or circulating leptin concentrations. However, modest reductions (24 -33 %) in the NEFA response to an adrenaline challenge were observed in two investigations where cows were treated with the trans-10,cis-12-CLA isomer compared with the control and treatment with cis-9,trans-11-CLA (Baumgard et al. 2002) . Hence, there was no indication of increased fat mobilisation in lactating cows abomasally infused with trans-10,cis-12-CLA isomer. In the present study, pigs received a mixture of CLA isomers that was particularly enriched with both cis-9,trans-11-and the trans-10,cis-12-CLA isomers, which may in part explain the differences. In addition, adipose tissue from lactating dairy cows is much more sensitive (10 -100-fold) to catecholamines than adipose tissue from growing pigs (Pethick & Dunshea, 1993) . Thus, although the studies used similar doses of adrenaline they would have been conducted on the ascending phase and plateau phase of the doseresponse curve in pigs and cows respectively. Therefore, dietary CLA may have increased sensitivity to adrenaline in pigs (present study) while decreasing maximal responsiveness in cows (Baumgard et al. 2000 (Baumgard et al. , 2001a , two scenarios that are not mutually exclusive. Regardless, it is still unlikely that increased fat mobilisation is a major proportion of the reduction in fat deposition during dietary CLA supplementation in pigs.
After adrenaline injection, the plasma glucose levels in pigs fed diets high in fat and CLA-fed pigs were lower than the control pigs, suggesting that there might be small changes in the ability of the pig liver to respond to adrenergic stimulation due to dietary fat and CLA. The importance of these metabolic adaptations to dietary fat and CLA supplementation is unknown.
Conclusion
In conclusion, results from the present study suggest that there were no interactions between dietary energy source and CLA. Dietary CLA-reduced fat accretion in pigs appears to be largely due to a reduced rate of lipogenesis from preformed fatty acids, possibly through reduced lipoprotein lipase activity, and to lesser extent, increased lipolysis. Results from the present study show that plasma triacylglycerol and NEFA concentrations are increased during CLA feeding in pigs suggesting alterations in both the uptake of pre-formed fatty acids and fat breakdown. However, defining the mechanism(s) of CLA requires a more definitive understanding of specific dimensions of lipid metabolism that are responding to CLA treatment. Further, studies are needed to determine activities of key lipogenic enzymes involved in the lipid transport and metabolism in adipose tissue from CLA-treated pigs.
